Step 3: ProCLA Essential (Hit Stubborn Areas) by PC Laboratories
Step 3 of our PC Laboratories Fat Loss System is the next step in the process that will allow you to release Subcutaneous Adipose White Fat, also known as Stubborn Fat, that typically deposits on the stomach, hips, and thighs. Studies have also established that a clinical dose of CLA can maintain lean muscle tone, boost metabolism, and support healthy immune function.
The CLA Enzymic Process
Enzymes: Enzymes are the biological substance (proteins) that act as Catalysts and help complex reactions occur everywhere in life. Enzymes work like locks and keys, they complete very specific jobs and do nothing else. They are very specific locks and the compounds (Substrates) they work with are the special keys. In this instance, we are looking at a specific Lipase Enzyme.
Substrate: A Substrate is a biological molecule that the enzyme will work on and it needs to be in the same area as the Enzymes.
Activators: Activators are compounds that make enzymes work harder and faster. Sometimes your body can produce an Activator on its own accord. Sometimes you may eat something that acts as an activator. In this instance, Conjugated Linoleic Acid (CLA) is a fatty acid that is an Activator. Activators can also help the Catalysts bind to the Substrate
This is how CLA works to kick start an enzymic process that will target Stubborn Fat on the stomach, hips & thighs:
- By taking CLA you are releasing a powerful Activator into your digestive system. CLA triggers the activation of specific Lipase Enzymes that start to work harder and faster at their designated function – breaking down their Substrate – in this case, the Substrate is the fatty acid compound (CLA).
- Once an Enzyme has performed it’s function it “let’s go”, returns to normal, ready to do another reaction. The dosage of CLA taken is very small and is broken down quickly by the Lipase Enzymes. So, with no CLA remaining to break down, the Lipase Enzyme can find another Substrate with a very similar structure to continue its work.
- The only Substrate present with the same structure as CLA is Subcutaneous Adipose White Fat, aka stubborn fat on the stomach, hips & thighs. The Lipase Enzymes continue to perform their function on the new Substrate.
How to take ProCLA Essential:
Take 2 Softgels 3 times per day with 250-500ml of water with your main meals. Drink at least 3 litres of water spread evenly throughout the day while using ProCLA. Use ProCLA in conjunction with PC Laboratories ProBurn and ProALCAR+ for best results.
ProCLA Essential Ingredients:
Ingredients: (Conjugated Linoleic Acid, Oleic Acid, Palmatic Acid, Stearic Acid, Linoleic Acid, Gelatin, Glycerin, Purified Water, Caramel Colour (E150)). Packaged in Australia from local and imported ingredients. This product contains no gluten, milk, eggs, wheat, soybeans, peanuts, tree nuts, fish or shellfish.
WARNING: Do not take ProCLA Essential in excess of its recommended dosage. ProCLA Essential is intended only for adults over 18. Consult a licensed health-care practitioner before use. Do not use if you are pregnant, nursing or if you have a family history of heart disease, high blood pressure, stroke or any other disease, or using a prescription drug, or over-the- counter drug. Discontinue
use immediately if you experience any adverse reactions. KEEP OUT OF REACH OF CHILDREN
ProCLA Essential References:
- Conjugated linoleic acid supplementation alters the 6-mo change in fat oxidation during sleep | https://www.ncbi.nlm.nih.gov/pubmed/17823448?dopt=Abstract | Mixed isomer CLA supplementation, but not placebo, positively altered fat oxidation and energy expenditure during sleep.
- The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain. | https://www.ncbi.nlm.nih.gov/pubmed/16924272?dopt=Abstract | CLA supplementation among overweight adults significantly reduced body fat over 6 months and prevented weight gain during the holiday season. No adverse effects were seen.
- Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. | https://www.ncbi.nlm.nih.gov/pubmed/15159244/ | Long-term supplementation with CLA-FFA or CLA-triacylglycerol reduces Body Fat Mass in healthy overweight adults.
- Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. | https://www.ncbi.nlm.nih.gov/pubmed/15795434/ | This study shows that CLA supplementation for 24 mo in healthy, overweight adults was well tolerated. It confirms also that CLA decreases BFM in overweight humans, and may help maintain initial reductions in BFM and weight in the long term.
- Conjugated linoleic acid reduces body fat mass in overweight and obese humans. | https://www.ncbi.nlm.nih.gov/pubmed/11110851?dopt=Abstract | Repeated-measures analysis showed that a significantly higher reduction in BFM was found in the conjugated linoleic acid groups compared with the placebo group
- Influence of conjugated linoleic acid on body composition and target gene expression in peroxisome proliferator-activated receptor alpha-null mice. | https://www.ncbi.nlm.nih.gov/pubmed/11731333?dopt=Abstract | CLA causes increased levels of mRNAs encoding lipid metabolizing and mitochondrial uncoupling proteins that likely contribute to the mechanisms underlying reduced fat/increased lean body mass resulting from consumption of dietary CLA.
- Conjugated linoleic acid (CLA), body fat, and apoptosis. | https://www.ncbi.nlm.nih.gov/pubmed/11316347 |CLA consumption causes apoptosis in white adipose tissue. This effect occurs within 5 days of consuming a diet that contains CLA.
- Conjugated linoleic acid persistently increases total energy expenditure in AKR/J mice without increasing uncoupling protein gene expression. | https://www.ncbi.nlm.nih.gov/pubmed/11015475 |CLA treatment reduced adipose depot weights by approximately 50% but had no significant effects on either body weight or energy intake. CLA increased EE persistently by an average of 7.7% throughout the 5-wk experiment.
- Trans-10, cis-12 conjugated linoleic acid increases fatty acid oxidation in 3T3-L1 preadipocytes. | https://www.ncbi.nlm.nih.gov/pubmed/11880570 | Proven